Epizyme, Inc.
CEO
Robert Bazemore
IPO Date
2013-05-31
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Epizyme (EPZM) Reports Q2 Loss, Tops Revenue Estimates
Epizyme Announces CEO Succession
Epizyme Reports Second Quarter 2021 Financial Results and Provides Business Update
Epizyme and HUTCHMED Announce Strategic Collaboration to Develop and Commercialize TAZVERIKยฎ (tazemetostat) in Greater China
Why Epizyme Stock Is Falling This Week
Epizyme: Potential Comeback With Tazemetostat After Initial Sales Challenge
Epizyme's Multiple Myeloma Drug Candidate Inhibits Tumors In Animal Models